Citation data

OpenAlex

Works that cite this article, indexed by OpenAlex.

24 resultsUpdated November 10, 2026
1

Cellular death, reactive oxygen species (ROS) and diabetic complications

Cell Death and Disease 9(2) (2018)

Caroline Maria Oliveira Volpe; Pedro Henrique Villar-Delfino; Paula Martins Ferreira dos Anjos; José Augusto Nogueira‐Machado

2

Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis

Kidney International 96(2) (2019)

Jonatan Barrera‐Chimal; Sophie Girerd; Frédéric Jaisser

4

Nonepithelial mineralocorticoid receptor activation as a determinant of kidney disease

Kidney International Supplements 12(1) (2022)

Toshifumi Nakamura; Sophie Girerd; Frédéric Jaisser; Jonatan Barrera‐Chimal

5

Spironolactone Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Rats

Journal of Diabetes Research 2018 (2018)

Wenjuan Liu; Wei Gong; Min He; Yemei Liu; Yeping Yang; Meng Wang; Meng Wu; Shizhe Guo; Yifei Yu; Xuanchun Wang; Fei Sun; Yiming Li; Zhou Linuo; Shengmei Qin; Zhaoyun Zhang

6

Cerebro-Cardiovascular Risk, Target Organ Damage, and Treatment Outcomes in Primary Aldosteronism

Frontiers in Cardiovascular Medicine 8 (2022)

Xiao Lin; Muhammad Hasnain Ehsan Ullah; Wu Xiong; Feng Xu; Su‐Kang Shan; Li-Min Lei; Ling‐Qing Yuan; Jun Liu

7

COVID-19—The Potential Beneficial Therapeutic Effects of Spironolactone during SARS-CoV-2 Infection

Pharmaceuticals 14(1) (2021)

Katarzyna Kotfis; Kacper Lechowicz; Sylwester Drożdżal; Paulina Niedźwiedzka‐Rystwej; Tomasz Kazimierz Wojdacz; Ewelina Grywalska; Jowita Biernawska; Magda Wiśniewska; Miłosz Parczewski

8

Drug Targets for Oxidative Podocyte Injury in Diabetic Nephropathy

Cureus 7(12) (2015)

Adnan Bashir Bhatti; Muhammad Ali Usman

9

Spironolactone ameliorates endothelial dysfunction through inhibition of the AGE/RAGE axis in a chronic renal failure rat model

BMC Nephrology 20(1) (2019)

Chun‐Cheng Wang; An‐Sheng Lee; Shuhui Liu; Kuan‐Cheng Chang; Ming‐Yi Shen; Chiz‐Tzung Chang

10

Vascular mineralocorticoid receptor activation and disease

Experimental Eye Research 188 (2019)

Jonatan Barrera‐Chimal; Frédéric Jaisser

11

Cardiovascular Disease in Obstructive Sleep Apnea: Putative Contributions of Mineralocorticoid Receptors

International Journal of Molecular Sciences 24(3) (2023)

Mohammad Badran; Shawn B. Bender; David Gozal

13

Clinical Properties and Non-Clinical Testing of Mineralocorticoid Receptor Antagonists in In Vitro Cell Models

International Journal of Molecular Sciences 25(16) (2024)

Luka Varda; Robert Ekart; Mitja Lainščak; Uroš Maver; Sebastjan Bevc

14

Roles of aldosterone in vascular calcification: An update

European Journal of Pharmacology 786 (2016)

Jing‐Wei Gao; Kun Zhang; Jie Chen; Mong-Heng Wang; Jingfeng Wang; Pin‐Ming Liu; Hui Huang

15

Spironolactone reduces oxidative stress in living donor kidney transplantation: a randomized controlled trial

American Journal of Physiology-Renal Physiology 317(3) (2019)

Luis Eduardo Morales-Buenrostro; Juan Antonio Ortega-Trejo; Rosalba Pérez‐Villalva; Lluvia A. Marino; Yvett González-Bobadilla; Hilda Juárez; Flor M. Zamora-Mejía; Norma González; Ramón Espinoza; Jonatan Barrera‐Chimal; Norma Araceli Bobadilla

16

SRC‐3 Knockout Attenuates Myocardial Injury Induced by Chronic Intermittent Hypoxia in Mice

Oxidative Medicine and Cellular Longevity 2021(1) (2021)

Wanyu Wang; Hongbo Gu; Weihua Li; Yihua Lin; Xiangyang Yao; Wen Luo; Fang Lu; Shenhui Huang; Yonghong Shi; Zhengrong Huang

17

Acute effect of mineralocorticoid receptor antagonism on vascular function in healthy older adults

Experimental Gerontology 73 (2015)

Moon‐Hyon Hwang; Jeung‐Ki Yoo; Meredith J. Luttrell; Han‐Kyul Kim; Thomas H. Meade; Mark W. English; Susanne Talcott; Iris Zamir Jaffe; Demetra D. Christou

19

Parenteral Nutrition and Cardiotoxicity

Cardiovascular Toxicology 21(4) (2021)

Johan van Nispen; Marcus Voigt; Eric Song; Austin T. Armstrong; Margarita Fedorova; Vidul Murali; Joseph Krebs; Ashish Samaddar; Chandrashekhara Manithody; Ajay Kumar Jain

20

Vascular and inflammatory mineralocorticoid receptors in kidney disease

Acta Physiologica 228(2) (2019)

Jonatan Barrera‐Chimal; Frédéric Jaisser

21

Therapeutic effects of spironolactone on a collagen-induced arthritis model of rheumatoid arthritis

The Egyptian Rheumatologist 39(2) (2016)

Inderjeet Verma; Ashit Syngle; Pawan Krishan

22

Aldosterone/MR Signaling, Oxidative Stress, and Vascular Dysfunction

IntechOpen eBooks (2019)

Ana María Briones; Rhian M. Touyz

23

Therapeutic potential of spironolactone in ankylosing spondylitis patients: Relation to disease activity and functional status

The Egyptian Rheumatologist 43(2) (2020)

Inderjeet Verma; Pawan Krishan; Ashit Syngle